Ambry Genetics is First Authorized Customer Service Provider in New Ion Torrent CSP Program

April 04, 2011

FOR IMMEDIATE RELEASE

Ambry Genetics
1 Enterprise
Aliso Viejo, CA 92656


Aliso Viejo, CA - April 4, 2011 – Ambry Genetics announced today that it is the first authorized customer service provider (CSP) in Ion Torrent's new service provider program. Ion Torrent's CSP certification assures customers that the organization they are trusting with their samples has been trained and tested by Ion Torrent to produce the highest quality sequence data.

Ion Torrent has revolutionized DNA sequencing by enabling a direct connection between chemical and digital information through the use of proven semiconductor technology. The result is a sequencing system that is simpler, faster, less expensive and more scalable than other sequencing technologies.

The Ion Torrent Authorized CSP Program gives scientists an easy way to take advantage of the speed and affordability of Ion semiconductor sequencing.

"We've been generating data with the Ion Personal Genome Machine (PGM™) for six months and are excited about launching services on this platform and being the first customer service provider," said Charles Dunlop, CEO of Ambry Genetics. "This machine has the ability to change the way sequencing is done." "

"Ever since the launch of the Ion PGM sequencer, we have gotten numerous requests to sequence various types of samples," said Ardy Arianpour, Vice President of Business Development at Ambry Genetics. "We are currently taking orders and lining up customers who want to experience the Personal Genome Machine.""

"Ambry Genetics was one of our first early access sites and now we are very pleased to have them as our first Ion Torrent Authorized Customer Service Provider for the Ion PGM," said Maneesh Jain, Vice President of Marketing and Business Development.

Click the link below to view the special video announcement! http://www.youtube.com/watch?v=Kg9D4zEC16M

Or to view in HD click the link below. http://www.youtube.com/watch?v=Kg9D4zEC16M&hd=1


About Life Technologies

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific and medical advancements that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance the fields of discovery and translational research, molecular medicine, stem cell-based therapies, food safety and animal health, and 21st century forensics. The company manufactures both molecular diagnostic and research use only products. Life Technologies' industry-leading brands are found in nearly every life sciences lab in the world and include innovative instrument systems under the Applied Biosystems and Ion Torrent names, as well as, the broadest range of reagents with its Invitrogen, GIBCO, Ambion, Molecular Probes and Taqman products. Life Technologies had sales of $3.6 billion in 2010, has a workforce of approximately 11,000 people, has a presence in approximately 160 countries, and possesses one of the largest intellectual property estates in the life sciences industry, with approximately 3,900 patents and exclusive licenses. For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com.

About Ambry Genetics ®

Ambry Genetics, a subsidiary of REALM IDx, Inc., translates scientific research into clinically actionable test results based upon a deep understanding of the human genome and the biology behind genetic disease. It is a leader in genetic testing that aims to improve health by understanding the relationship between genetics and disease. Its unparalleled track record of discoveries over 25 years, and growing database that continues to expand in collaboration with academic, corporate and pharmaceutical partners, means Ambry Genetics is first to market with innovative products and comprehensive analysis that enable clinicians to confidently inform patient health decisions.

Media Contact
Mickie Henshall
Chief Marketing Officer
REALM IDx
mhenshall@realmidx.com

Search Results

Start your search...